Rockefeller Capital Management
AYTU icon

Rockefeller Capital Management’s AYTU BioPharma AYTU Stock Holding History

Rockefeller Capital Management’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27 Buy
+10
New +$26 ﹤0.01% 4659

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CAM
Crown Advisors Management Larkspur, California $151M AUM 73.11% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $268M AUM 158.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rockefeller Capital Management's AYTU Position: Q1 2026 in Review

Rockefeller Capital Management opened a new position in AYTU BioPharma (AYTU) in Q1 2026: 10 shares worth $27. The stake represents ﹤0.01% of the portfolio and ranks #4659 among its holdings.

37 funds tracked by Wall St. Rank hold AYTU as of Q1 2026.

  • Rockefeller Capital Management held 10 shares of AYTU BioPharma worth $27 as of Q1 2026.
  • AYTU BioPharma was a new Rockefeller Capital Management position in Q1 2026.
  • AYTU BioPharma made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4659 holding.
  • 37 funds tracked by Wall St. Rank held AYTU BioPharma as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.